GSK1070806
219538
Phase 2 small_molecule terminated
Quick answer
GSK1070806 for Dermatitis, Atopic is a Phase 2 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Dermatitis, Atopic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated